---
title: "Charles River Labs CEVP Shannon Parisotto disposes of shares worth $1,038,051.24"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295844385.md"
description: "Shannon M. Parisotto, Charles River Laboratories' CEVP for Discovery & Safety Assessment, exercised options for 3,714 shares at $179.66 and sold them at $279.66 on August 11, 2026. The transaction totaled approximately $1,038,051.24. Following the sale, she retains direct ownership of 4,807 shares."
datetime: "2026-08-13T20:42:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295844385.md)
  - [en](https://longbridge.com/en/news/295844385.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295844385.md)
generator: "portal-rs"
---

# Charles River Labs CEVP Shannon Parisotto disposes of shares worth $1,038,051.24

-   Shannon M. Parisotto, CEVP, Discovery & Safety Assessment, reported an option exercise in Charles River Laboratories on Aug. 11, 2026. \* Exercised stock options for 3,714 shares at USD 179.66. \* Sold 3,714 shares at USD 279.66, leaving 4,807 shares owned directly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001100682-26-000130), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)

## Related News & Research

- [Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52](https://longbridge.com/en/news/296533503.md)
- [Insider Move at Charles River Labs: Director Cashes In on Company Stock](https://longbridge.com/en/news/296571643.md)
- [Charles River and MVC to develop enterovirus vaccine](https://longbridge.com/en/news/296594849.md)
- [Charles River partners with Medigen Vaccine Biologics on NGS-backed multivalent enterovirus vaccine development](https://longbridge.com/en/news/296486690.md)
- [Charles River EVP, Chief People Officer Victoria Creamer sells 4,179 shares for $1.08 million](https://longbridge.com/en/news/295447796.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**